| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |